Company Profile

PharmaBio Company Profile

Contract manufacturing and consulting company specializing in cellular and tissue based products

Given an emerging worldwide attention to regenerative medicine and cellular and tissue based products, expectation for development of cellular and tissue based products with established effectiveness and safety within the framework of the Pharmaceutical Affairs Law is bigger now than ever. We, as a contract manufacturer specializing in cellular and tissue based products, support GCTP-compliant production of investigational new drugs while reducing the burden of risk and cost, and provide consultation related to development strategies and applications for regulatory approval.

Company name PharmaBio Corporation
Establishment April 1978 (Name change in October 2010)
Representatives Hitoshi Kusano, President and CEO
Capital JPY 215,027,500
Business description Contract manufacturing of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment, etc.
Number of employees 25
Address ■Head Office / R&D
4-14-17 Kaminagoya, Nishi-ku Nagoya, Aichi 451-0025, Japan
■Tokyo Administrative Division
AIOS Nagatacho 612, 2-17-17 Nagatacho,Chiyoda-ku, Tokyo
100-0014, Japan

Head Office / R&D Map

Head Office / R&D

  • Address: 4-14-17 Kaminagoya, Nishi-ku, Nagoya, Aichi 451-0025, Japan
  • Tel: +81-52-508-5701
  • Fax: +81-52-521-7430

Tokyo Administrative Division

Tokyo Administrative Division

  • Address: AIOS Nagatacho 612, 2-17-17 Nagatacho,Chiyoda-ku, Tokyo
    100-0014, Japan
  • Tel: +81-3-6205-4101
  • Fax: +81-3-6205-4102

Our Business

We contribute to medical and social progress by pioneering potential new therapies as we pursue the development of cell and tissue based medicines for the Japanese market.